Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy

Journal of Clinical Microbiology

Volumn 41, Issue 5, 2003, Pages 2153-2155

  O'Connell, Robert J ^a   Merritt, Teresa M ^a   Malia, Jennifer A ^b   VanCott, Thomas C ^c   Dolan, Matthew J ^a   Zahwa, Hassan ^b   Bradley, William P ^c   Branson, Bernard M ^d   Michael, Nelson L ^b   De Witt, Caroline C ^a  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIRETROVIRUS AGENT; PROTEIN GP41 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; PERFORMANCE; PRIORITY JOURNAL; SAMPLING; SENSITIVITY AND SPECIFICITY; SERUM; VIRUS DIAGNOSIS; WESTERN BLOTTING;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BLOTTING, WESTERN; CASE-CONTROL STUDIES; FALSE NEGATIVE REACTIONS; FEMALE; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; MOUTH MUCOSA; SENSITIVITY AND SPECIFICITY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0038289185     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.5.2153-2155.2003     Document Type: Article

References (12)

1. Bakari, J. P., S. McKenna, A. Myrick, K. Mwinga, G. J. Bhat, and S. Allen. 2000. Rapid voluntary testing and counseling for HIV. Acceptability and feasibility in Zambian antenatal care clinics. Ann. N. Y. Acad. Sci. 918:64-76.
2. Centers for Disease Control and Prevention. 2001. Routinely recommended HIV testing at an urgent-care clinic, Atlanta, Georgia, 2000. Mortal. Wkly. Rep. 50:538-541.
3. Centers for Disease Control and Prevention. 1998. Update: HIV counseling and testing using rapid tests - United States, 1995. Morb. Mortal. Wkly. Rep. 47:211-215.
4. Dorn, J., S. Masciotra, C. Yang, R. Downing, B. Biryahwaho, T. D. Mastro, J. Nkengasong, D. Pieniazek, M. A. Rayfield, D. J. Hu, and R. B. Lal. 2000. Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection. J. Clin. Microbiol. 38:773-780.
5. Giles, R. E., K. R. Perry, and J. V. Parry. 1999. Simple/rapid test devices for anti-HIV screening: do they come up to the mark? J. Med. Virol. 59:104-109.
6. Henderson, D. K. 1999. Postexposure chemoprophylaxis for occupational exposures to the human immunodeficiency virus. JAMA 281:931-936.
7. Kim, J., J. Mascola, S. Ratto-Kim, T. VanCott, L. Loomis-Price, J. Cox, N. Michael, L. Jagodinski, J. Mansfield, C. Hawkes, D. Mayers, B. Gilliam, D. Birx, and M. Robb. 2001. Selected increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infection. AIDS Res. Hum. Retrovir. 17:1021-1034.
8. McKenna, S. L., G. K. Muyinda, D. Roth, M. Mwali, N. Ng'andu, A. Myrick, C. Luo, F. H. Priddy, V. M. Hall, A. A. von Lieven, J. R. Sabatino, K. Mark, and S. A. Allen. 1997. Rapid HIV testing and counseling for voluntary testing centers in Africa. AIDS 11:S103-S110.
9. Morris, L., J. M. Binley, B. A. Clas, S. Bonhoeffer, T. P. Astill, R. Kost, A. Hurley, Y. Cao, M. Markowitz, D. D. Ho, and J. P. Moore. 1998. HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J. Exp. Med. 188:233-245.
10. VanCott, T. C., J. R. Mascola, R. W. Kaminski, V. Kalyanaraman, P. L. Hallberg, P. R. Burnett, J. T. Ulrich, D. J. Rechtman, and D. L. Blrx. 1997. Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160. J. Virol. 71:4319-4330.
11. Wiley, D. J., R. R. Frerichs, W. L. Ford, and P. A. Simon. 1998. Failure to learn human immunodeficiency virus test results in Los Angeles public sexually transmitted disease clinics. Sex. Transm. Dis. 25:342-345.
12. Wilkinson, D., N. Wilkinson, C. Lombard, D. Martin, A. Smith, K. Floyd, and R. Ballard. 1997. On-site HIV testing in resource-poor settings: is one rapid test enough? AIDS 11:377-381.